WebGalvanize Therapeutics has raised a total of $148.5M in funding over 4 rounds. Their latest funding was raised on Sep 15, 2024 from a Series B round. Galvanize Therapeutics is funded by 4 investors. Gilmartin Capital LLC and Fidelity Management and Research Company are the most recent investors. Galvanize Therapeutics has acquired 2 … WebGalvanize Therapeutics Inc. SIC Code 80,804. NAICS Code 62,621. Show More. Galvanize Org Chart. Jonathan Waldstreic... Founder & Chief Executive Of... Phone Email. ... Slide to rate Jonathan Waldstreicher as a Founder & Chief Executive Officer. 5. Worse Best. Submit. View Employees. Doug Krotine. Senior Director, Sales (US) Phone Email.
Apple Tree Partners Galvanize Therapeutics Announces...
WebSep 15, 2024 · Galvanize Therapeutics, Inc., a commercial-stage biomedical platform company operating at the convergence of engineering, biology and healthcare delivery, … WebThe Aliya TM System is 510 (k) cleared in the United States for the surgical ablation of soft tissue. It is not currently commercially available in any other geography. Galvanize Therapeutics does not promote the off-label use of its products and nothing herein is intended to promote an off-label use of the Aliya System. fiestaware travel mug
Galvanize Therapeutics Announces Merger to Create the Premier …
WebHeadquarters Location. 1531 Industrial Road . San Carlos, California, 94070, United States. 650-268-4252 WebMar 1, 2024 · GALVANIZE Therapeutics: Michael Iversen [email protected] +1 520 400 9190. SOURCE Galvanize Therapeutics. WebSep 15, 2024 · Galvanize Therapeutics, Inc., a commercial-stage biomedical platform company operating at the convergence of engineering, biology and healthcare delivery, today announced it has completed a $100 million Series B financing to advance and commercialize its unique AliyaTM Pulsed Electric Field (PEF) energy platform. griff bandy